Rank | Gene Set | Z-score |
---|---|---|
1 | omega-hydroxylase P450 pathway (GO:0097267) | 9.40478760 |
2 | epoxygenase P450 pathway (GO:0019373) | 9.36909869 |
3 | exogenous drug catabolic process (GO:0042738) | 9.19992422 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.60140966 |
5 | L-phenylalanine catabolic process (GO:0006559) | 7.60140966 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26149283 |
7 | L-phenylalanine metabolic process (GO:0006558) | 7.26149283 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.83963006 |
9 | drug metabolic process (GO:0017144) | 6.39293932 |
10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.35595047 |
11 | tryptophan catabolic process (GO:0006569) | 6.18944601 |
12 | indole-containing compound catabolic process (GO:0042436) | 6.18944601 |
13 | indolalkylamine catabolic process (GO:0046218) | 6.18944601 |
14 | oxidative demethylation (GO:0070989) | 6.09692455 |
15 | kynurenine metabolic process (GO:0070189) | 6.07022968 |
16 | ethanol metabolic process (GO:0006067) | 6.05820648 |
17 | bile acid biosynthetic process (GO:0006699) | 5.93063262 |
18 | tryptophan metabolic process (GO:0006568) | 5.82482046 |
19 | glyoxylate metabolic process (GO:0046487) | 5.80615959 |
20 | negative regulation of fibrinolysis (GO:0051918) | 5.67295081 |
21 | urea metabolic process (GO:0019627) | 5.63725773 |
22 | urea cycle (GO:0000050) | 5.63725773 |
23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.60954151 |
24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.60121235 |
25 | regulation of fibrinolysis (GO:0051917) | 5.47409988 |
26 | protein carboxylation (GO:0018214) | 5.42532890 |
27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.42532890 |
28 | cysteine metabolic process (GO:0006534) | 5.42123164 |
29 | regulation of plasminogen activation (GO:0010755) | 5.34833398 |
30 | regulation of protein activation cascade (GO:2000257) | 5.34336264 |
31 | complement activation, alternative pathway (GO:0006957) | 5.34297856 |
32 | sulfur amino acid catabolic process (GO:0000098) | 5.33464553 |
33 | nitrogen cycle metabolic process (GO:0071941) | 5.18234641 |
34 | serine family amino acid catabolic process (GO:0009071) | 5.15765442 |
35 | bile acid metabolic process (GO:0008206) | 5.10331594 |
36 | phenylpropanoid metabolic process (GO:0009698) | 5.08344508 |
37 | regulation of complement activation (GO:0030449) | 4.97445057 |
38 | aromatic amino acid family metabolic process (GO:0009072) | 4.96725184 |
39 | regulation of humoral immune response (GO:0002920) | 4.91880366 |
40 | regulation of cholesterol esterification (GO:0010872) | 4.89344136 |
41 | reverse cholesterol transport (GO:0043691) | 4.89239674 |
42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86570582 |
43 | negative regulation of blood coagulation (GO:0030195) | 4.84892284 |
44 | negative regulation of hemostasis (GO:1900047) | 4.84892284 |
45 | acute-phase response (GO:0006953) | 4.81162351 |
46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.79943660 |
47 | protein-lipid complex remodeling (GO:0034368) | 4.79943660 |
48 | macromolecular complex remodeling (GO:0034367) | 4.79943660 |
49 | tyrosine metabolic process (GO:0006570) | 4.78782520 |
50 | homocysteine metabolic process (GO:0050667) | 4.76455448 |
51 | regulation of triglyceride catabolic process (GO:0010896) | 4.76202804 |
52 | negative regulation of protein activation cascade (GO:2000258) | 4.72585241 |
53 | alpha-amino acid catabolic process (GO:1901606) | 4.66107648 |
54 | lysine catabolic process (GO:0006554) | 4.65016811 |
55 | lysine metabolic process (GO:0006553) | 4.65016811 |
56 | acylglycerol homeostasis (GO:0055090) | 4.62365641 |
57 | triglyceride homeostasis (GO:0070328) | 4.62365641 |
58 | negative regulation of sterol transport (GO:0032372) | 4.62311502 |
59 | negative regulation of cholesterol transport (GO:0032375) | 4.62311502 |
60 | amino-acid betaine metabolic process (GO:0006577) | 4.60417529 |
61 | phospholipid efflux (GO:0033700) | 4.59465204 |
62 | cellular ketone body metabolic process (GO:0046950) | 4.52136577 |
63 | S-adenosylmethionine metabolic process (GO:0046500) | 4.48084790 |
64 | glycine metabolic process (GO:0006544) | 4.44136806 |
65 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.43762110 |
66 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.43762110 |
67 | bile acid and bile salt transport (GO:0015721) | 4.42589664 |
68 | plasma lipoprotein particle clearance (GO:0034381) | 4.42548992 |
69 | negative regulation of coagulation (GO:0050819) | 4.41142504 |
70 | imidazole-containing compound metabolic process (GO:0052803) | 4.41016566 |
71 | indolalkylamine metabolic process (GO:0006586) | 4.38446861 |
72 | negative regulation of wound healing (GO:0061045) | 4.38388306 |
73 | coenzyme catabolic process (GO:0009109) | 4.34877022 |
74 | cellular glucuronidation (GO:0052695) | 4.30537677 |
75 | glutamate metabolic process (GO:0006536) | 4.29563173 |
76 | cellular biogenic amine catabolic process (GO:0042402) | 4.29126716 |
77 | amine catabolic process (GO:0009310) | 4.29126716 |
78 | cellular amino acid catabolic process (GO:0009063) | 4.28972083 |
79 | cholesterol efflux (GO:0033344) | 4.25414742 |
80 | serine family amino acid metabolic process (GO:0009069) | 4.21711158 |
81 | alkaloid metabolic process (GO:0009820) | 4.19030777 |
82 | benzene-containing compound metabolic process (GO:0042537) | 4.13884071 |
83 | ethanol oxidation (GO:0006069) | 4.11974763 |
84 | positive regulation of hemostasis (GO:1900048) | 4.11379801 |
85 | positive regulation of blood coagulation (GO:0030194) | 4.11379801 |
86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.08943294 |
87 | cellular modified amino acid catabolic process (GO:0042219) | 4.08258630 |
88 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.06463857 |
89 | serine family amino acid biosynthetic process (GO:0009070) | 4.06314845 |
90 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.04493763 |
91 | plasma lipoprotein particle assembly (GO:0034377) | 4.03613325 |
92 | fibrinolysis (GO:0042730) | 4.02773367 |
93 | drug catabolic process (GO:0042737) | 4.00144588 |
94 | aldehyde catabolic process (GO:0046185) | 3.99106055 |
95 | arginine metabolic process (GO:0006525) | 3.99091018 |
96 | hormone catabolic process (GO:0042447) | 3.95793457 |
97 | ketone body metabolic process (GO:1902224) | 3.91436289 |
98 | negative regulation of complement activation (GO:0045916) | 3.89520192 |
99 | blood coagulation, intrinsic pathway (GO:0007597) | 3.88236430 |
100 | glucuronate metabolic process (GO:0019585) | 3.82436768 |
101 | uronic acid metabolic process (GO:0006063) | 3.82436768 |
102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78892427 |
103 | phospholipid homeostasis (GO:0055091) | 3.78214491 |
104 | positive regulation of coagulation (GO:0050820) | 3.77575146 |
105 | cofactor catabolic process (GO:0051187) | 3.77152083 |
106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.76167335 |
107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.76167335 |
108 | complement activation, classical pathway (GO:0006958) | 3.75854322 |
109 | organic acid catabolic process (GO:0016054) | 3.74969959 |
110 | carboxylic acid catabolic process (GO:0046395) | 3.74969959 |
111 | cholesterol homeostasis (GO:0042632) | 3.74691450 |
112 | flavonoid metabolic process (GO:0009812) | 3.74176430 |
113 | positive regulation of lipid catabolic process (GO:0050996) | 3.73897284 |
114 | complement activation (GO:0006956) | 3.73181108 |
115 | protein activation cascade (GO:0072376) | 3.73131513 |
116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.72997685 |
117 | short-chain fatty acid metabolic process (GO:0046459) | 3.72630265 |
118 | negative regulation of lipase activity (GO:0060192) | 3.71255988 |
119 | sterol homeostasis (GO:0055092) | 3.68682481 |
120 | regulation of cholesterol homeostasis (GO:2000188) | 3.67224660 |
121 | acetyl-CoA metabolic process (GO:0006084) | 3.66977717 |
122 | plasma lipoprotein particle organization (GO:0071827) | 3.64522526 |
123 | acute inflammatory response (GO:0002526) | 3.63544591 |
124 | protein-lipid complex assembly (GO:0065005) | 3.61751274 |
125 | response to mercury ion (GO:0046689) | 3.59495936 |
126 | cytolysis (GO:0019835) | 3.59474402 |
127 | intestinal cholesterol absorption (GO:0030299) | 3.57224151 |
128 | sodium-independent organic anion transport (GO:0043252) | 3.56404642 |
129 | xenobiotic metabolic process (GO:0006805) | 3.54415011 |
130 | opsonization (GO:0008228) | 3.54372582 |
131 | NAD biosynthetic process (GO:0009435) | 3.52523352 |
132 | regulation of acute inflammatory response (GO:0002673) | 3.48336373 |
133 | regulation of apoptotic cell clearance (GO:2000425) | 3.44778294 |
134 | heme transport (GO:0015886) | 3.39817613 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41817623 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21655752 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.04664661 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51291711 |
5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.14266230 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.11859927 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.81088196 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04800553 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.03556643 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06693094 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9872674 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99735335 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94377093 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62605979 |
15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57683652 |
16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53373671 |
17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41839813 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38086597 |
19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26185054 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25675682 |
21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20000708 |
22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19216883 |
23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16293458 |
24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08584611 |
25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04621814 |
26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01239086 |
27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00382372 |
28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97967123 |
29 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.96910469 |
30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92714594 |
31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92450511 |
32 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.91542093 |
33 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90752704 |
34 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.87978026 |
35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86921159 |
36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86649046 |
37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.85790251 |
38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83596561 |
39 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83547599 |
40 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83398566 |
41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82966603 |
42 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.82669925 |
43 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82247693 |
44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79142352 |
45 | NFYA_21822215_ChIP-Seq_K562_Human | 0.78512802 |
46 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78087601 |
47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77242626 |
48 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.76855918 |
49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76332016 |
50 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76278890 |
51 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73991551 |
52 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73491382 |
53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72650894 |
54 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72231677 |
55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.71045161 |
56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70756153 |
57 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.69181963 |
58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68348635 |
59 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68139790 |
60 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67869823 |
61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66925269 |
62 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.66438406 |
63 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64985905 |
64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64952349 |
65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64952349 |
66 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.64739728 |
67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63281525 |
68 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63184736 |
69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.62089266 |
70 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.61900316 |
71 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61102883 |
72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60950133 |
73 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60942732 |
74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60033582 |
75 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.59458795 |
76 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.58788187 |
77 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.57703583 |
78 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57438086 |
79 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.55044175 |
80 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.54704930 |
81 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.54582851 |
82 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.54219230 |
83 | NFYB_21822215_ChIP-Seq_K562_Human | 0.54197835 |
84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53874653 |
85 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.53869808 |
86 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53411021 |
87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53186366 |
88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52929768 |
89 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.52676036 |
90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52235723 |
91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52039562 |
92 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.51837089 |
93 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51588037 |
94 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.51440963 |
95 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.50991961 |
96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.50841038 |
97 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.50703457 |
98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.50626263 |
99 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50552144 |
100 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50285490 |
101 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.49735869 |
102 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.49716716 |
103 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.49639190 |
104 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.49602154 |
105 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.49561999 |
106 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.49484049 |
107 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.48851730 |
108 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48844990 |
109 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.48759224 |
110 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.48749655 |
111 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48326284 |
112 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.47726130 |
113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46617935 |
114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46133217 |
115 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46120084 |
116 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45256500 |
117 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.44984151 |
118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44156499 |
119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43287215 |
120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42553106 |
121 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42440597 |
122 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41969068 |
123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41942256 |
124 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41792480 |
125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41262515 |
126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40922444 |
127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40804784 |
128 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40744194 |
129 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.40299822 |
130 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40140482 |
131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39930051 |
132 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39875114 |
133 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37995297 |
134 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.37407596 |
135 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36782639 |
136 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36098454 |
137 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35943341 |
138 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33917675 |
139 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33836288 |
140 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33800300 |
141 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33667815 |
142 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.32027456 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.32979813 |
2 | MP0005360_urolithiasis | 7.62927654 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.42013549 |
4 | MP0005365_abnormal_bile_salt | 6.15294518 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.09533646 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.31614475 |
7 | MP0003252_abnormal_bile_duct | 3.89127520 |
8 | MP0010329_abnormal_lipoprotein_level | 3.59851827 |
9 | MP0009840_abnormal_foam_cell | 3.26833521 |
10 | MP0005083_abnormal_biliary_tract | 3.15771401 |
11 | MP0003195_calcinosis | 2.89166025 |
12 | MP0005332_abnormal_amino_acid | 2.78661962 |
13 | MP0001666_abnormal_nutrient_absorption | 2.60564954 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.29289053 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.16747335 |
16 | MP0000609_abnormal_liver_physiology | 2.15665387 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.09644464 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.96469746 |
19 | MP0003868_abnormal_feces_composition | 1.88632333 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82438447 |
21 | MP0001764_abnormal_homeostasis | 1.65610184 |
22 | MP0009697_abnormal_copulation | 1.62457196 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57719338 |
24 | MP0005451_abnormal_body_composition | 1.42212807 |
25 | MP0003011_delayed_dark_adaptation | 1.35317928 |
26 | MP0003186_abnormal_redox_activity | 1.26337597 |
27 | MP0009643_abnormal_urine_homeostasis | 1.26227121 |
28 | MP0003656_abnormal_erythrocyte_physiolo | 1.22620837 |
29 | MP0000598_abnormal_liver_morphology | 1.17197161 |
30 | MP0003705_abnormal_hypodermis_morpholog | 1.14537639 |
31 | MP0005647_abnormal_sex_gland | 1.14254363 |
32 | MP0000604_amyloidosis | 1.09924298 |
33 | MP0009764_decreased_sensitivity_to | 1.04904389 |
34 | MP0002254_reproductive_system_inflammat | 1.03436361 |
35 | MP0009763_increased_sensitivity_to | 1.01852943 |
36 | MP0010368_abnormal_lymphatic_system | 0.99431255 |
37 | MP0005636_abnormal_mineral_homeostasis | 0.95190473 |
38 | MP0008469_abnormal_protein_level | 0.88750183 |
39 | MP0009642_abnormal_blood_homeostasis | 0.87215204 |
40 | MP0005408_hypopigmentation | 0.86226118 |
41 | MP0006036_abnormal_mitochondrial_physio | 0.82124950 |
42 | MP0002282_abnormal_trachea_morphology | 0.82091855 |
43 | MP0001915_intracranial_hemorrhage | 0.81818484 |
44 | MP0005084_abnormal_gallbladder_morpholo | 0.81209111 |
45 | MP0005376_homeostasis/metabolism_phenot | 0.78886543 |
46 | MP0009765_abnormal_xenobiotic_induced | 0.78097116 |
47 | MP0002078_abnormal_glucose_homeostasis | 0.77725203 |
48 | MP0002876_abnormal_thyroid_physiology | 0.77684182 |
49 | MP0005220_abnormal_exocrine_pancreas | 0.75397348 |
50 | MP0005670_abnormal_white_adipose | 0.72211255 |
51 | MP0002971_abnormal_brown_adipose | 0.71198442 |
52 | MP0001661_extended_life_span | 0.71158869 |
53 | MP0005187_abnormal_penis_morphology | 0.71112325 |
54 | MP0005334_abnormal_fat_pad | 0.68901899 |
55 | MP0003879_abnormal_hair_cell | 0.67774804 |
56 | MP0003690_abnormal_glial_cell | 0.67645938 |
57 | MP0004130_abnormal_muscle_cell | 0.67197147 |
58 | MP0005535_abnormal_body_temperature | 0.67195766 |
59 | MP0009053_abnormal_anal_canal | 0.66122350 |
60 | MP0003329_amyloid_beta_deposits | 0.63968417 |
61 | MP0005266_abnormal_metabolism | 0.63496280 |
62 | MP0001756_abnormal_urination | 0.61409614 |
63 | MP0002249_abnormal_larynx_morphology | 0.60677978 |
64 | MP0000639_abnormal_adrenal_gland | 0.60522142 |
65 | MP0009785_altered_susceptibility_to | 0.59875067 |
66 | MP0006035_abnormal_mitochondrial_morpho | 0.57174974 |
67 | MP0005448_abnormal_energy_balance | 0.55774738 |
68 | MP0005464_abnormal_platelet_physiology | 0.53563323 |
69 | MP0005023_abnormal_wound_healing | 0.52567806 |
70 | MP0005395_other_phenotype | 0.49133053 |
71 | MP0002822_catalepsy | 0.48745600 |
72 | MP0002136_abnormal_kidney_physiology | 0.47948592 |
73 | MP0003638_abnormal_response/metabolism_ | 0.47290639 |
74 | MP0002928_abnormal_bile_duct | 0.47203810 |
75 | MP0003718_maternal_effect | 0.45068810 |
76 | MP0008874_decreased_physiological_sensi | 0.45046649 |
77 | MP0000566_synostosis | 0.43510406 |
78 | MP0003724_increased_susceptibility_to | 0.43414856 |
79 | MP0008873_increased_physiological_sensi | 0.43122164 |
80 | MP0004782_abnormal_surfactant_physiolog | 0.43027161 |
81 | MP0003436_decreased_susceptibility_to | 0.42695649 |
82 | MP0003953_abnormal_hormone_level | 0.41182454 |
83 | MP0003075_altered_response_to | 0.40939053 |
84 | MP0002837_dystrophic_cardiac_calcinosis | 0.40310815 |
85 | MP0005248_abnormal_Harderian_gland | 0.39228532 |
86 | MP0005166_decreased_susceptibility_to | 0.37365145 |
87 | MP0009672_abnormal_birth_weight | 0.37231652 |
88 | MP0002332_abnormal_exercise_endurance | 0.36174965 |
89 | MP0008872_abnormal_physiological_respon | 0.36109131 |
90 | MP0005666_abnormal_adipose_tissue | 0.34763251 |
91 | MP0006082_CNS_inflammation | 0.33972036 |
92 | MP0004381_abnormal_hair_follicle | 0.33529648 |
93 | MP0000579_abnormal_nail_morphology | 0.32985734 |
94 | MP0002168_other_aberrant_phenotype | 0.32256460 |
95 | MP0000249_abnormal_blood_vessel | 0.32249298 |
96 | MP0009115_abnormal_fat_cell | 0.31953832 |
97 | MP0002796_impaired_skin_barrier | 0.31623371 |
98 | MP0004883_abnormal_blood_vessel | 0.31366175 |
99 | MP0000467_abnormal_esophagus_morphology | 0.31235343 |
100 | MP0000230_abnormal_systemic_arterial | 0.30992098 |
101 | MP0001243_abnormal_dermal_layer | 0.30674819 |
102 | MP0002970_abnormal_white_adipose | 0.29689445 |
103 | MP0001853_heart_inflammation | 0.29401711 |
104 | MP0009384_cardiac_valve_regurgitation | 0.28847332 |
105 | MP0001845_abnormal_inflammatory_respons | 0.27901008 |
106 | MP0001881_abnormal_mammary_gland | 0.26810678 |
107 | MP0005397_hematopoietic_system_phenotyp | 0.26734100 |
108 | MP0001545_abnormal_hematopoietic_system | 0.26734100 |
109 | MP0002132_abnormal_respiratory_system | 0.24970041 |
110 | MP0005164_abnormal_response_to | 0.24538930 |
111 | MP0005058_abnormal_lysosome_morphology | 0.23054079 |
112 | MP0002135_abnormal_kidney_morphology | 0.22692661 |
113 | MP0003959_abnormal_lean_body | 0.22592001 |
114 | MP0001851_eye_inflammation | 0.21496536 |
115 | MP0001986_abnormal_taste_sensitivity | 0.21313488 |
116 | MP0002128_abnormal_blood_circulation | 0.19839651 |
117 | MP0000920_abnormal_myelination | 0.18736101 |
118 | MP0001944_abnormal_pancreas_morphology | 0.17770978 |
119 | MP0005197_abnormal_uvea_morphology | 0.16778937 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.51360580 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.38787034 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.31976055 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.64844485 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.60812115 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.46823541 |
7 | Xanthomatosis (HP:0000991) | 6.24706584 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.53798596 |
9 | Complement deficiency (HP:0004431) | 5.32772588 |
10 | Joint hemorrhage (HP:0005261) | 4.88701024 |
11 | Hypolipoproteinemia (HP:0010981) | 4.81729911 |
12 | Hyperammonemia (HP:0001987) | 4.60339671 |
13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.53207491 |
14 | Hyperglycinemia (HP:0002154) | 4.48697878 |
15 | Epidermoid cyst (HP:0200040) | 4.44629672 |
16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.39846603 |
17 | Ketosis (HP:0001946) | 4.27504105 |
18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22175491 |
19 | Abnormality of methionine metabolism (HP:0010901) | 4.18725661 |
20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17406900 |
21 | Hypoalphalipoproteinemia (HP:0003233) | 4.16522119 |
22 | Fat malabsorption (HP:0002630) | 4.15404590 |
23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09088250 |
24 | Hyperglycinuria (HP:0003108) | 3.98679780 |
25 | Abnormality of glycine metabolism (HP:0010895) | 3.97904864 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.97904864 |
27 | Abnormality of complement system (HP:0005339) | 3.88384606 |
28 | Hypoglycemic coma (HP:0001325) | 3.87581022 |
29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81241200 |
30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.78390554 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.78202862 |
32 | Hypercholesterolemia (HP:0003124) | 3.63917153 |
33 | Hyperbilirubinemia (HP:0002904) | 3.35047158 |
34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32822771 |
35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30127152 |
36 | Delayed CNS myelination (HP:0002188) | 3.16929014 |
37 | Steatorrhea (HP:0002570) | 3.11239495 |
38 | Spontaneous abortion (HP:0005268) | 3.07988388 |
39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07379167 |
40 | Ketoacidosis (HP:0001993) | 3.07223035 |
41 | Abnormality of serum amino acid levels (HP:0003112) | 3.07040964 |
42 | Hepatocellular carcinoma (HP:0001402) | 2.98167307 |
43 | Myocardial infarction (HP:0001658) | 2.96142557 |
44 | Hypochromic microcytic anemia (HP:0004840) | 2.95937587 |
45 | Fair hair (HP:0002286) | 2.92256126 |
46 | Neonatal hypoglycemia (HP:0001998) | 2.90133082 |
47 | Osteomalacia (HP:0002749) | 2.78553824 |
48 | Metabolic acidosis (HP:0001942) | 2.76404189 |
49 | Skin nodule (HP:0200036) | 2.74412344 |
50 | Abnormality of purine metabolism (HP:0004352) | 2.71873473 |
51 | Systemic lupus erythematosus (HP:0002725) | 2.70493552 |
52 | Vascular calcification (HP:0004934) | 2.64709323 |
53 | Lethargy (HP:0001254) | 2.60269317 |
54 | Acanthocytosis (HP:0001927) | 2.59806826 |
55 | Dicarboxylic aciduria (HP:0003215) | 2.58852715 |
56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.58852715 |
57 | Glomerulonephritis (HP:0000099) | 2.53368197 |
58 | Gout (HP:0001997) | 2.51319188 |
59 | Hypoglycemic seizures (HP:0002173) | 2.50360868 |
60 | Purpura (HP:0000979) | 2.48595161 |
61 | Abnormal gallbladder morphology (HP:0012437) | 2.45133338 |
62 | Spastic diplegia (HP:0001264) | 2.44656428 |
63 | Mitral stenosis (HP:0001718) | 2.43590479 |
64 | Cerebral edema (HP:0002181) | 2.40843435 |
65 | Cholelithiasis (HP:0001081) | 2.38433930 |
66 | Irritability (HP:0000737) | 2.34741277 |
67 | Pulmonary embolism (HP:0002204) | 2.34711386 |
68 | Cardiovascular calcification (HP:0011915) | 2.34703273 |
69 | Neonatal onset (HP:0003623) | 2.34018170 |
70 | Malnutrition (HP:0004395) | 2.31115614 |
71 | Cholecystitis (HP:0001082) | 2.30324902 |
72 | Abnormal gallbladder physiology (HP:0012438) | 2.30324902 |
73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29033999 |
74 | Amyloidosis (HP:0011034) | 2.28654446 |
75 | Gingival bleeding (HP:0000225) | 2.23534019 |
76 | Esophageal varix (HP:0002040) | 2.22749648 |
77 | Menorrhagia (HP:0000132) | 2.19324698 |
78 | Pancreatitis (HP:0001733) | 2.13977364 |
79 | Late onset (HP:0003584) | 2.13561789 |
80 | Sensorimotor neuropathy (HP:0007141) | 2.12768320 |
81 | Hyperphosphaturia (HP:0003109) | 2.12634188 |
82 | Thrombophlebitis (HP:0004418) | 2.11813465 |
83 | Enlarged kidneys (HP:0000105) | 2.11725116 |
84 | Vomiting (HP:0002013) | 2.08056136 |
85 | Brushfield spots (HP:0001088) | 2.07765741 |
86 | Generalized aminoaciduria (HP:0002909) | 2.07553067 |
87 | Reduced antithrombin III activity (HP:0001976) | 2.05480552 |
88 | Generalized hypopigmentation of hair (HP:0011358) | 2.04611422 |
89 | Poikilocytosis (HP:0004447) | 2.03290438 |
90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02774219 |
91 | Opisthotonus (HP:0002179) | 2.02522397 |
92 | Hemorrhage of the eye (HP:0011885) | 2.02187637 |
93 | Elevated alkaline phosphatase (HP:0003155) | 1.99421491 |
94 | Abnormality of the gallbladder (HP:0005264) | 1.98701828 |
95 | Rickets (HP:0002748) | 1.95828077 |
96 | Arthropathy (HP:0003040) | 1.93339000 |
97 | Abnormality of iron homeostasis (HP:0011031) | 1.89426859 |
98 | Increased serum ferritin (HP:0003281) | 1.89087051 |
99 | Alkalosis (HP:0001948) | 1.88998715 |
100 | Hypophosphatemic rickets (HP:0004912) | 1.88652324 |
101 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87910443 |
102 | Hydroxyprolinuria (HP:0003080) | 1.87098696 |
103 | Abnormality of proline metabolism (HP:0010907) | 1.87098696 |
104 | Abnormal cartilage morphology (HP:0002763) | 1.85277345 |
105 | Joint swelling (HP:0001386) | 1.84582058 |
106 | Abnormality of urine glucose concentration (HP:0011016) | 1.83776500 |
107 | Glycosuria (HP:0003076) | 1.83776500 |
108 | Renal cortical cysts (HP:0000803) | 1.83667442 |
109 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83366745 |
110 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.81604055 |
111 | Blue irides (HP:0000635) | 1.80400932 |
112 | Elevated hepatic transaminases (HP:0002910) | 1.79434218 |
113 | Nephritis (HP:0000123) | 1.79302047 |
114 | Abnormality of the Achilles tendon (HP:0005109) | 1.77758132 |
115 | Status epilepticus (HP:0002133) | 1.77441029 |
116 | Gangrene (HP:0100758) | 1.77206259 |
117 | Epistaxis (HP:0000421) | 1.75061985 |
118 | Abnormality of vitamin metabolism (HP:0100508) | 1.74387833 |
119 | Proximal tubulopathy (HP:0000114) | 1.72185285 |
120 | Increased mean platelet volume (HP:0011877) | 1.72140406 |
121 | Abnormal urine phosphate concentration (HP:0012599) | 1.69794422 |
122 | Bifid scrotum (HP:0000048) | 1.68399262 |
123 | Cerebral palsy (HP:0100021) | 1.63364294 |
124 | Abnormal platelet volume (HP:0011876) | 1.55529506 |
125 | Atrioventricular block (HP:0001678) | 1.53971206 |
126 | Reticulocytosis (HP:0001923) | 1.50744689 |
127 | Abnormal biliary tract physiology (HP:0012439) | 1.49540979 |
128 | Bile duct proliferation (HP:0001408) | 1.49540979 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.18522793 |
2 | FGFR4 | 4.68973599 |
3 | SIK1 | 4.68175283 |
4 | ERN1 | 4.28864755 |
5 | TAOK3 | 3.15708995 |
6 | INSRR | 3.01564102 |
7 | ERBB4 | 2.80153732 |
8 | PKN2 | 2.32074742 |
9 | MAP2K4 | 2.29038503 |
10 | MST1R | 2.14530274 |
11 | PRPF4B | 2.06217415 |
12 | PIK3CG | 1.97021097 |
13 | FLT3 | 1.93723614 |
14 | MAPK11 | 1.84525834 |
15 | TRIB3 | 1.78787569 |
16 | TYK2 | 1.73906974 |
17 | NTRK3 | 1.72287065 |
18 | LATS1 | 1.64615581 |
19 | DAPK2 | 1.62382069 |
20 | PTK6 | 1.50604786 |
21 | ABL2 | 1.45460423 |
22 | FGFR2 | 1.39799312 |
23 | FRK | 1.38289260 |
24 | WNK3 | 1.37985392 |
25 | NEK9 | 1.37642052 |
26 | KDR | 1.34089225 |
27 | JAK2 | 1.22786483 |
28 | NLK | 1.22101617 |
29 | MAP3K7 | 1.20962018 |
30 | TNK2 | 1.18546051 |
31 | FER | 1.12460267 |
32 | PINK1 | 1.11606706 |
33 | PRKAA2 | 1.11591960 |
34 | CAMKK2 | 1.07048221 |
35 | GRK6 | 1.04749463 |
36 | MAP2K3 | 1.03801781 |
37 | TBK1 | 1.03058719 |
38 | JAK1 | 1.02469148 |
39 | BLK | 1.01459001 |
40 | ERBB2 | 1.00232462 |
41 | MAP3K10 | 0.98642830 |
42 | MAP3K14 | 0.97253242 |
43 | MAPK4 | 0.95785318 |
44 | MYLK | 0.94153899 |
45 | PRKG1 | 0.93412521 |
46 | PRKCZ | 0.91946650 |
47 | STK38L | 0.90532855 |
48 | PRKACA | 0.87393441 |
49 | MET | 0.85818764 |
50 | EPHB1 | 0.85764622 |
51 | MAPK15 | 0.84659517 |
52 | MAP3K2 | 0.82568529 |
53 | MAP3K3 | 0.82503208 |
54 | CDK6 | 0.80601710 |
55 | TIE1 | 0.79348438 |
56 | MAPK12 | 0.78449654 |
57 | PRKACG | 0.75949545 |
58 | EPHA3 | 0.75885557 |
59 | MAP3K11 | 0.74784393 |
60 | CAMK1D | 0.73845962 |
61 | DYRK1B | 0.71933872 |
62 | MUSK | 0.71682491 |
63 | CSK | 0.70964573 |
64 | ZAP70 | 0.69399402 |
65 | GSK3A | 0.68340812 |
66 | PDK2 | 0.67818803 |
67 | CAMK2G | 0.66468903 |
68 | CSNK1D | 0.66360626 |
69 | PRKAA1 | 0.66335131 |
70 | SGK3 | 0.64155606 |
71 | MAP2K6 | 0.64061332 |
72 | CAMKK1 | 0.63694266 |
73 | AKT3 | 0.62735534 |
74 | TGFBR2 | 0.62102389 |
75 | RIPK1 | 0.61893292 |
76 | SCYL2 | 0.60896323 |
77 | KIT | 0.60657687 |
78 | FGFR3 | 0.58913398 |
79 | IRAK3 | 0.57235265 |
80 | PTK2 | 0.56579293 |
81 | RPS6KA3 | 0.56465242 |
82 | PRKCB | 0.55821858 |
83 | MAPK7 | 0.55549215 |
84 | CSF1R | 0.55044444 |
85 | IKBKE | 0.52882692 |
86 | PRKACB | 0.52548310 |
87 | SRC | 0.51694304 |
88 | EPHA4 | 0.51568448 |
89 | PRKCQ | 0.50603632 |
90 | PDPK1 | 0.50074922 |
91 | SGK1 | 0.49224191 |
92 | CSNK1G1 | 0.48868113 |
93 | SGK2 | 0.48766495 |
94 | GRK1 | 0.45607532 |
95 | CSNK1E | 0.45176838 |
96 | IGF1R | 0.44105262 |
97 | TAOK2 | 0.43298132 |
98 | RET | 0.42726634 |
99 | BRSK2 | 0.41472295 |
100 | MAP3K13 | 0.41409563 |
101 | MAP3K5 | 0.40498533 |
102 | CDK4 | 0.40116961 |
103 | PRKCG | 0.39734986 |
104 | PDGFRA | 0.39553592 |
105 | MAP2K1 | 0.39342740 |
106 | CSNK2A1 | 0.38461710 |
107 | ARAF | 0.38306684 |
108 | SGK223 | 0.37618150 |
109 | SGK494 | 0.37618150 |
110 | ICK | 0.36802231 |
111 | MTOR | 0.35571104 |
112 | PKN1 | 0.34684825 |
113 | CSNK2A2 | 0.34614605 |
114 | PBK | 0.32866219 |
115 | MAP3K6 | 0.32611068 |
116 | CAMK4 | 0.32289709 |
117 | EGFR | 0.32269883 |
118 | PDK1 | 0.31683593 |
119 | MAPK3 | 0.31078624 |
120 | STK16 | 0.30128457 |
121 | CAMK1G | 0.27511933 |
122 | CSNK1G2 | 0.26971725 |
123 | MAP3K1 | 0.26274447 |
124 | PRKCA | 0.25845489 |
125 | IRAK1 | 0.24428255 |
126 | IRAK2 | 0.24007414 |
127 | CSNK1G3 | 0.23512799 |
128 | PDK3 | 0.23424339 |
129 | PDK4 | 0.23424339 |
130 | LATS2 | 0.22866835 |
131 | PIK3CA | 0.22062380 |
132 | PAK3 | 0.21545501 |
133 | ABL1 | 0.20477519 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.46538164 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.63092931 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40665061 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.33410947 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04118924 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78249409 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70970183 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68919422 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65761410 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53413912 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48333992 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40170683 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28311065 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18522269 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14874886 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.06494439 |
17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96083354 |
18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.95557805 |
19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93841013 |
20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93371573 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91944193 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84066633 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81085226 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78824087 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78536417 |
26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73106007 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71794445 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71248629 |
29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68549542 |
30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65749373 |
31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65194871 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58949626 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54611746 |
34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51506735 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.50818314 |
36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47718754 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43101879 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36859068 |
39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36062410 |
40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32128695 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28694793 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28558482 |
43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20898927 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.20800086 |
45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19986977 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18945058 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17335170 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12841787 |
49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04603462 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02221080 |
51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01562679 |
52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97992894 |
53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96554599 |
54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93669890 |
55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92514341 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88022864 |
57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86916659 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85027607 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.82420467 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77526504 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69863717 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68169202 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64835695 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56396799 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53389540 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48202548 |
67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45615863 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39310416 |
69 | Pertussis_Homo sapiens_hsa05133 | 0.37298005 |
70 | Prion diseases_Homo sapiens_hsa05020 | 0.33520624 |
71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25340738 |
72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25096903 |
73 | Insulin resistance_Homo sapiens_hsa04931 | 0.22834122 |
74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22606989 |
75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21194304 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21156892 |
77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20152354 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14204653 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08942626 |
80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01181456 |
81 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2951416 |
82 | Amoebiasis_Homo sapiens_hsa05146 | -0.2455787 |
83 | Bladder cancer_Homo sapiens_hsa05219 | -0.2450131 |
84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2414920 |
85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2334235 |
86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2299859 |
87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2183250 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2160578 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2156819 |
90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1953959 |
91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1944355 |
92 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1936462 |
93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1877054 |
94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1774952 |
95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1699844 |
96 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1697585 |
97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1588942 |
98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1548518 |
99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1502895 |
100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1468479 |
101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1463723 |
102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1053335 |
103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0876104 |
104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0847612 |
105 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0744423 |
106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0680530 |
107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0435568 |
108 | Mineral absorption_Homo sapiens_hsa04978 | -0.0272726 |
109 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0139362 |